Clinical Trial Update: Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update for SPARC0912 and Reference0912 in open angle glaucoma and ocular hypertension; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Reference0912
• SPARC0912

Snippet

Sponsor: Sun Pharma Advanced Research Company Limited | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2016-05-30